The Neurobiology of Zika Virus

Neuron

Volumn 92, Issue 5, 2016, Pages 949-958

  Li, Hongda ^a,b   Saucedo Cuevas, Laura ^a,b   Shresta, Sujan ^c   Gleeson, Joseph G ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

acute flaccid paralysis; antibody mediated enhancement; flavivirus; Guillain Barr syndrome; interferon; microcephaly; neurovirology; vertical transmission; Zika

Indexed keywords

INTERFERON; MEMBRANE RECEPTOR; ZIKA VIRUS VACCINE;

ACUTE DISEASE; BRAIN CALCIFICATION; BRAIN MALFORMATION; CELL SURVIVAL; CLINICAL OUTCOME; CONGENITAL RUBELLA SYNDROME; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERADICATION THERAPY; EYE MALFORMATION; FLACCID PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MENINGOENCEPHALITIS; MICROCEPHALY; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROBIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PANDEMIC; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; SIGNAL TRANSDUCTION; SYNDROME; VERTICAL TRANSMISSION; VIROLOGY; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION; ZIKA FEVER; ZIKA VIRUS; BLINDNESS; BRAIN; COGNITIVE DEFECT; FEMALE; IMMUNOLOGY; NEWBORN; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RETINA NERVE CELL;

BLINDNESS; BRAIN; CELL SURVIVAL; COGNITIVE DYSFUNCTION; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFANT, NEWBORN; INTERFERONS; MENINGOENCEPHALITIS; MICROCEPHALY; NEURAL STEM CELLS; NEUROGENESIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETINAL NEURONS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85003766095     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2016.11.031     Document Type: Review

References (74)

1. Adibi, J.J., Marques, E.T. Jr., Cartus, A., Beigi, R.H., Teratogenic effects of the Zika virus and the role of the placenta. Lancet 387 (2016), 1587–1590.
2. Aguirre, S., Maestre, A.M., Pagni, S., Patel, J.R., Savage, T., Gutman, D., Maringer, K., Bernal-Rubio, D., Shabman, R.S., Simon, V., et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog., 8, 2012, e1002934.
3. Aliota, M.T., Caine, E.A., Walker, E.C., Larkin, K.E., Camacho, E., Osorio, J.E., Characterization of lethal Zika virus infection in AG129 mice. PLoS Negl. Trop. Dis., 10, 2016, e0004682.
4. Araújo, F., Nogueira, R., Araújo, Mde.S., Perdigão, A., Cavalcanti, L., Brilhante, R., Rocha, M., Vilar, D.F., Holanda, S.S., Braga, Dde.M., Sidrim, J., Dengue in patients with central nervous system manifestations, Brazil. Emerg. Infect. Dis. 18 (2012), 677–679.
5. Ashour, J., Morrison, J., Laurent-Rolle, M., Belicha-Villanueva, A., Plumlee, C.R., Bernal-Rubio, D., Williams, K.L., Harris, E., Fernandez-Sesma, A., Schindler, C., García-Sastre, A., Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 8 (2010), 410–421.
6. Barba-Spaeth, G., Dejnirattisai, W., Rouvinski, A., Vaney, M.C., Medits, I., Sharma, A., Simon-Lorière, E., Sakuntabhai, A., Cao-Lormeau, V.M., Haouz, A., et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536 (2016), 48–53.
7. Bayer, A., Lennemann, N.J., Ouyang, Y., Bramley, J.C., Morosky, S., Marques, E.T. Jr., Cherry, S., Sadovsky, Y., Coyne, C.B., Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe 19 (2016), 705–712.
8. Brasil, P., Pereira, J.P. Jr., Raja Gabaglia, C., Damasceno, L., Wakimoto, M., Ribeiro Nogueira, R.M., Carvalho de Sequeira, P., Machado Siqueira, A., Abreu de Carvalho, L.M., Cotrim da Cunha, D., et al. Zika virus infection in pregnant women in Rio de Janeiro—Preliminary report. N. Engl. J. Med., 2016, 10.1056/NEJMoa1602412.
9. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387 (2016), 1531–1539.
10. Carod-Artal, F.J., Wichmann, O., Farrar, J., Gascón, J., Neurological complications of dengue virus infection. Lancet Neurol. 12 (2013), 906–919.
11. Castanha, P.M., Cordeiro, M.T., Martelli, C.M., Souza, W.V., Marques, E.T. Jr., Braga, C., Force of infection of dengue serotypes in a population-based study in the northeast of Brazil. Epidemiol. Infect. 141 (2013), 1080–1088.
12. CDC Department of Health and Human Services. Achievements in public health: elimination of rubella and congenital rubella syndrome-US, 1969-2004. Ann. Pharmacother. 39 (2005), 1151–1152.
13. Centers for Disease Control and Prevention (CDC). Achievements in public health. Reduction in perinatal transmission of HIV infection–United States, 1985-2005. MMWR Morb. Mortal. Wkly. Rep. 55 (2006), 592–597.
14. Chen, J., Harrison, D.E., Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood. Blood 99 (2002), 561–566.
15. Cugola, F.R., Fernandes, I.R., Russo, F.B., Freitas, B.C., Dias, J.L., Guimarães, K.P., Benazzato, C., Almeida, N., Pignatari, G.C., Romero, S., et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534 (2016), 267–271.
16. Dang, J., Tiwari, S.K., Lichinchi, G., Qin, Y., Patil, V.S., Eroshkin, A.M., Rana, T.M., Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell 19 (2016), 258–265.
17. de Paula Freitas, B., de Oliveira Dias, J.R., Prazeres, J., Sacramento, G.A., Ko, A.I., Maia, M., Belfort, R. Jr., Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol., 2016, 10.1001/jamaophthalmol.2016.0267.
18. Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.M., Malasit, P., Rey, F.A., et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 17 (2016), 1102–1108.
19. Dick, G.W., Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 521–534.
20. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
21. Dowall, S.D., Graham, V.A., Rayner, E., Atkinson, B., Hall, G., Watson, R.J., Bosworth, A., Bonney, L.C., Kitchen, S., Hewson, R., A susceptible mouse model for Zika virus infection. PLoS Negl. Trop. Dis., 10, 2016, e0004658.
22. Duffy, M.R., Chen, T.H., Hancock, W.T., Powers, A.M., Kool, J.L., Lanciotti, R.S., Pretrick, M., Marfel, M., Holzbauer, S., Dubray, C., et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360 (2009), 2536–2543.
23. Furtado, J.M., Espósito, D.L., Klein, T.M., Teixeira-Pinto, T., da Fonseca, B.A., Uveitis associated with Zika virus infection. N. Engl. J. Med. 375 (2016), 394–396.
24. Garcez, P.P., Loiola, E.C., Madeiro da Costa, R., Higa, L.M., Trindade, P., Delvecchio, R., Nascimento, J.M., Brindeiro, R., Tanuri, A., Rehen, S.K., Zika virus impairs growth in human neurospheres and brain organoids. Science 352 (2016), 816–818.
25. Grant, A., Ponia, S.S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., Schwarz, M.C., Sánchez-Seco, M.P., Evans, M.J., Best, S.M., García-Sastre, A., Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 19 (2016), 882–890.
26. Halstead, S.B., Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol. Spectr., 2, 2014, 10.1128/microbiolspec.AID-0022-2014.
27. Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., Perera-Lecoin, M., Surasombatpattana, P., Talignani, L., Thomas, F., et al. Biology of Zika virus infection in human skin cells. J. Virol. 89 (2015), 8880–8896.
28. Ibanez, C.E., Schrier, R., Ghazal, P., Wiley, C., Nelson, J.A., Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65 (1991), 6581–6588.
29. Ishikawa, T., Yamanaka, A., Konishi, E., A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine 32 (2014), 1326–1337.
30. Jones, C.A., Isaacs, D., Predicting the outcome of symptomatic congenital cytomegalovirus infection. J. Paediatr. Child Health 31 (1995), 70–71.
31. Kassavetis, P., Joseph, J.M., Francois, R., Perloff, M.D., Berkowitz, A.L., Zika virus-associated Guillain-Barré syndrome variant in Haiti. Neurology 87 (2016), 336–337.
32. Kimberlin, D.W., Lin, C.Y., Sánchez, P.J., Demmler, G.J., Dankner, W., Shelton, M., Jacobs, R.F., Vaudry, W., Pass, R.F., Kiell, J.M., et al., National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 143 (2003), 16–25.
33. Kimberlin, D.W., Jester, P.M., Sánchez, P.J., Ahmed, A., Arav-Boger, R., Michaels, M.G., Ashouri, N., Englund, J.A., Estrada, B., Jacobs, R.F., et al., National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N. Engl. J. Med. 372 (2015), 933–943.
34. Lazear, H.M., Govero, J., Smith, A.M., Platt, D.J., Fernandez, E., Miner, J.J., Diamond, M.S., A mouse model of Zika virus pathogenesis. Cell Host Microbe 19 (2016), 720–730.
35. Li, J., Loeb, J.A., Shy, M.E., Shah, A.K., Tselis, A.C., Kupski, W.J., Lewis, R.A., Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann. Neurol. 53 (2003), 703–710.
36. Li, C., Xu, D., Ye, Q., Hong, S., Jiang, Y., Liu, X., Zhang, N., Shi, L., Qin, C.F., Xu, Z., Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 19 (2016), 120–126.
37. Li, H., Saucedo-Cuevas, L., Regla-Nava, J.A., Chai, G., Sheets, N., Tang, W., Terskikh, A.V., Shresta, S., Gleeson, J.G., Zika virus infects neural progenitors in the adult mouse brain and alters proliferation. Cell Stem Cell 19 (2016), 593–598.
38. Liang, Q., Luo, Z., Zeng, J., Chen, W., Foo, S.S., Lee, S.A., Ge, J., Wang, S., Goldman, S.A., Zlokovic, B.V., et al. Zika virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy. Cell Stem Cell 19 (2016), 663–671.
39. Ludlow, M., Kortekaas, J., Herden, C., Hoffmann, B., Tappe, D., Trebst, C., Griffin, D.E., Brindle, H.E., Solomon, T., Brown, A.S., et al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol. 131 (2016), 159–184.
40. MacNamara, F.N., Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 48 (1954), 139–145.
41. Marceau, C.D., Puschnik, A.S., Majzoub, K., Ooi, Y.S., Brewer, S.M., Fuchs, G., Swaminathan, K., Mata, M.A., Elias, J.E., Sarnow, P., Carette, J.E., Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens. Nature 535 (2016), 159–163.
42. Mécharles, S., Herrmann, C., Poullain, P., Tran, T.H., Deschamps, N., Mathon, G., Landais, A., Breurec, S., Lannuzel, A., Acute myelitis due to Zika virus infection. Lancet, 387, 2016, 1481.
43. Meertens, L., Carnec, X., Lecoin, M.P., Ramdasi, R., Guivel-Benhassine, F., Lew, E., Lemke, G., Schwartz, O., Amara, A., The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12 (2012), 544–557.
44. Michaels, M.G., Greenberg, D.P., Sabo, D.L., Wald, E.R., Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr. Infect. Dis. J. 22 (2003), 504–509.
45. Miner, J.J., Cao, B., Govero, J., Smith, A.M., Fernandez, E., Cabrera, O.H., Garber, C., Noll, M., Klein, R.S., Noguchi, K.K., et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165 (2016), 1081–1091.
46. Miner, J.J., Sene, A., Richner, J.M., Smith, A.M., Santeford, A., Ban, N., Weger-Lucarelli, J., Manzella, F., Rückert, C., Govero, J., et al. Zika virus infection in mice causes panuveitis with shedding of virus in tears. Cell Rep. 16 (2016), 3208–3218.
47. Mlakar, J., Korva, M., Tul, N., Popović, M., Poljšak-Prijatelj, M., Mraz, J., Kolenc, M., Resman Rus, K., Vesnaver Vipotnik, T., Fabjan Vodušek, V., et al. Zika virus associated with microcephaly. N. Engl. J. Med. 374 (2016), 951–958.
48. Nowakowski, T.J., Pollen, A.A., Di Lullo, E., Sandoval-Espinosa, C., Bershteyn, M., Kriegstein, A.R., Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. Cell Stem Cell 18 (2016), 591–596.
49. Noyola, D.E., Demmler, G.J., Nelson, C.T., Griesser, C., Williamson, W.D., Atkins, J.T., Rozelle, J., Turcich, M., Llorente, A.M., Sellers-Vinson, S., et al., Houston Congenital CMV Longitudinal Study Group. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J. Pediatr. 138 (2001), 325–331.
50. Odeberg, J., Wolmer, N., Falci, S., Westgren, M., Seiger, A., Söderberg-Nauclér, C., Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 80 (2006), 8929–8939.
51. Onorati, M., Li, Z., Liu, F., Sousa, A.M., Nakagawa, N., Li, M., Dell'Anno, M.T., Gulden, F.O., Pochareddy, S., Tebbenkamp, A.T., et al. Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia. Cell Rep. 16 (2016), 2576–2592.
52. Perera-Lecoin, M., Meertens, L., Carnec, X., Amara, A., Flavivirus entry receptors: an update. Viruses 6 (2013), 69–88.
53. Petersen, L.R., Marfin, A.A., West Nile virus: a primer for the clinician. Ann. Intern. Med. 137 (2002), 173–179.
54. Priyamvada, L., Quicke, K.M., Hudson, W.H., Onlamoon, N., Sewatanon, J., Edupuganti, S., Pattanapanyasat, K., Chokephaibulkit, K., Mulligan, M.J., Wilson, P.C., et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. USA 113 (2016), 7852–7857.
55. Qian, X., Nguyen, H.N., Song, M.M., Hadiono, C., Ogden, S.C., Hammack, C., Yao, B., Hamersky, G.R., Jacob, F., Zhong, C., et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165 (2016), 1238–1254.
56. Rasmussen, S.A., Jamieson, D.J., Honein, M.A., Petersen, L.R., Zika virus and birth defects–reviewing the evidence for causality. N. Engl. J. Med. 374 (2016), 1981–1987.
57. Rossi, S.L., Tesh, R.B., Azar, S.R., Muruato, A.E., Hanley, K.A., Auguste, A.J., Langsjoen, R.M., Paessler, S., Vasilakis, N., Weaver, S.C., Characterization of a novel murine model to study Zika virus. Am. J. Trop. Med. Hyg. 94 (2016), 1362–1369.
58. Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B., Lemke, G., TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131 (2007), 1124–1136.
59. Savidis, G., McDougall, W.M., Meraner, P., Perreira, J.M., Portmann, J.M., Trincucci, G., John, S.P., Aker, A.M., Renzette, N., Robbins, D.R., et al. Identification of Zika virus and Dengue virus dependency factors using functional genomics. Cell Rep. 16 (2016), 232–246.
60. Schwartz, D.A., Autopsy and postmortem studies are concordant: Pathology of Zika virus infection is neurotropic in fetuses and infants with microcephaly following transplacental transmission. Arch. Pathol. Lab. Med., 2016, 10.5858/arpa.2016-0343-OA.
61. Screaton, G., Mongkolsapaya, J., Yacoub, S., Roberts, C., New insights into the immunopathology and control of dengue virus infection. Nat. Rev. Immunol. 15 (2015), 745–759.
62. Sejvar, J.J., Leis, A.A., Stokic, D.S., Van Gerpen, J.A., Marfin, A.A., Webb, R., Haddad, M.B., Tierney, B.C., Slavinski, S.A., Polk, J.L., et al. Acute flaccid paralysis and West Nile virus infection. Emerg. Infect. Dis. 9 (2003), 788–793.
63. Seth, R.B., Sun, L., Ea, C.K., Chen, Z.J., Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (2005), 669–682.
64. Soares de Oliveira-Szejnfeld, P., Levine, D., Melo, A.S., Amorim, M.M., Batista, A.G., Chimelli, L., Tanuri, A., Aguiar, R.S., Malinger, G., Ximenes, R., et al. Congenital brain abnormalities and Zika virus: What the radiologist can expect to see prenatally and postnatally. Radiology 281 (2016), 203–218.
65. Stettler, K., Beltramello, M., Espinosa, D.A., Graham, V., Cassotta, A., Bianchi, S., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353 (2016), 823–826.
66. Stoler-Poria, S., Lev, D., Schweiger, A., Lerman-Sagie, T., Malinger, G., Developmental outcome of isolated fetal microcephaly. Ultrasound Obstet. Gynecol. 36 (2010), 154–158.
67. Tabata, T., Petitt, M., Puerta-Guardo, H., Michlmayr, D., Wang, C., Fang-Hoover, J., Harris, E., Pereira, L., Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe 20 (2016), 155–166.
68. Tang, H., Hammack, C., Ogden, S.C., Wen, Z., Qian, X., Li, Y., Yao, B., Shin, J., Zhang, F., Lee, E.M., et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 18 (2016), 587–590.
69. Wu, K.Y., Zuo, G.L., Li, X.F., Ye, Q., Deng, Y.Q., Huang, X.Y., Cao, W.C., Qin, C.F., Luo, Z.G., Vertical transmission of Zika virus targeting the radial glial cells affects cortex development of offspring mice. Cell Res. 26 (2016), 645–654.
70. Yauch, L.E., Shresta, S., Dengue virus vaccine development. Adv. Virus Res. 88 (2014), 315–372.
71. Yockey, L.J., Varela, L., Rakib, T., Khoury-Hanold, W., Fink, S.L., Stutz, B., Szigeti-Buck, K., Van den Pol, A., Lindenbach, B.D., Horvath, T.L., Iwasaki, A., Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166 (2016), 1247–1256.e4.
72. Yu, C.Y., Chang, T.H., Liang, J.J., Chiang, R.L., Lee, Y.L., Liao, C.L., Lin, Y.L., Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog., 8, 2012, e1002780.
73. Zhang, F., Hammack, C., Ogden, S.C., Cheng, Y., Lee, E.M., Wen, Z., Qian, X., Nguyen, H.N., Li, Y., Yao, B., et al. Molecular signatures associated with ZIKV exposure in human cortical neural progenitors. Nucleic Acids Res. 44 (2016), 8610–8620.
74. Zhang, R., Miner, J.J., Gorman, M.J., Rausch, K., Ramage, H., White, J.P., Zuiani, A., Zhang, P., Fernandez, E., Zhang, Q., et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535 (2016), 164–168.